核子醫學市場規模、佔有率和成長分析：按診斷影像、治療應用、設備與技術、終端用戶、放射性藥物和地區分類－2026-2033年產業預測

2024 年全球核醫市場價值為 26 億美元，預計到 2025 年將成長至 28 億美元，到 2033 年將成長至 50.3 億美元，在預測期（2026-2033 年）內複合年成長率為 7.6%。

全球核子醫學市場受到癌症、神經系統疾病和心血管疾病等慢性病發病率上升的顯著影響，因此，先進的診斷方法對於早期發現和治療方案製定至關重要。 PET和SPECT等影像技術能夠提供分子層面的生物過程訊息，從而實現異常的早期檢測。這種高精確度對於有效的腫瘤治療實踐至關重要，包括腫瘤檢測和治療效果監測。此外，放射性藥物和影像技術的進步，例如混合系統和創新靶向放射性追蹤劑，正在提高診斷的準確性和安全性。治療診斷學（集診斷和治療於一體）的出現，透過進一步加速個人化醫療的發展並促進醫療專業人員的廣泛接受，推動了市場的持續成長。

全球核子醫學市場成長要素

全球核子醫學市場的主要促進因素之一是癌症和心血管疾病等慢性病的日益普遍，這些疾病需要先進的診斷和治療技術。核子醫學利用放射性藥物進行影像診斷和標靶治療，在這些疾病的早期發現和治療中發揮至關重要的作用。此外，人口老化導致對有效醫療干預的需求不斷成長，這進一步推動了核醫學技術的創新。醫護人員和病患對核醫益處的認知不斷提高，也促進了全球市場的擴張及其在臨床實務中的應用。

全球核子醫學市場限制因素

全球核子醫學市場面臨的主要限制因素之一是放射性藥物生產和分銷的嚴格法規結構。遵守嚴格的安全標準和許可要求對製造商構成重大挑戰，可能導致市場准入延遲和營運成本增加。此外，對放射性物質安全處理和處置的擔憂可能會阻礙潛在投資者，並限制設施擴張。日益成長的患者安全和環境影響方面的擔憂進一步加劇了這種情況，阻礙了創新，並降低了核醫學領域的整​​體成長潛力。

全球核子醫學市場趨勢

全球核子醫學市場正經歷顯著的發展趨勢，這主要得益於「診療整合」 （治療診斷學）技術的日益普及。該技術將診斷影像與標靶放射性藥物治療相結合，提高了腫瘤檢測的準確性，並實現了個人化治療方案的製定，從而能夠同時進行多種治療性介入，最終改善患者的治療效果。因此，市場對先進放射性示蹤劑的需求日益成長，尤其是在腫瘤學領域，其臨床應用也不斷擴展。精準醫療的興起正在重塑核子醫學的格局，推動市場成長，並促進旨在最佳化治療效果和患者照護的新技術和調查方法的發展。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球核子醫學市場規模：依診斷影像檢查

• SPECT影像
  • 心臟SPECT
  • 腫瘤SPECT
• PET影像
  • FDG-PET
  • 腫瘤PET

全球核子醫學市場規模：依治療應用分類

• 放射性藥物療法
  • I-131治療
  • 鐳-223療法
• 近距離放射治療
  • 永久植入式
  • 暫時植入

全球核子醫學市場規模：按設備和技術分類

• 影像設備
  • 伽馬攝影機
  • PET掃描儀
• 軟體解決方案
  • 影像分析軟體
  • 工作流程管理系統

全球核子醫學市場規模：依最終用戶分類

• 醫院
  • 大學醫院
  • 當地醫院
• 診斷中心
  • 門診設施
  • 專科診所

全球核子醫學市場規模：以放射性藥物分類

• 診斷用放射性藥物
  • Technetium-99m
  • 碘-123
• 用於治療的放射性藥物
  • 釔-90
  • 釤-153

全球核子醫學市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Siemens Healthineers
• GE Healthcare
• Philips Healthcare
• Bracco Imaging
• Cardinal Health
• Eli Lilly and Company
• Navidea Biopharmaceuticals
• Bayer AG
• Walgreens Boots Alliance
• Advanced Accelerator Applications
• Lantheus Medical Imaging
• Northstar Medical Radioisotopes
• IBA RadioPharma Solutions
• 3M Health Care
• Eczacibasi-Monrol
• TAE Life Sciences
• Medtronic
• PerkinElmer
• Roche Diagnostics
• Actinium Pharmaceuticals

結論與建議

Global Nuclear Medicine Market size was valued at USD 2.6 Billion in 2024 and is poised to grow from USD 2.8 Billion in 2025 to USD 5.03 Billion by 2033, growing at a CAGR of 7.6% during the forecast period (2026-2033).

The global nuclear medicine market is significantly influenced by the rising incidence of chronic diseases, including cancer, neurological disorders, and cardiovascular issues, necessitating sophisticated diagnostic methods for early detection and treatment planning. Techniques like PET and SPECT imaging provide invaluable insights into biological processes at the molecular level, enabling timely identification of abnormalities. This precision is crucial for effective oncology practices, including tumor detection and monitoring treatment responses. Additionally, technological advancements in radiopharmaceuticals and imaging technologies, such as hybrid systems and innovative targeted radiotracers, enhance diagnostic accuracy and safety. The emergence of theranostics, which merges diagnostics with treatment, further drives personalized medicine's growth and facilitates broader acceptance among healthcare providers, propelling the market's continual progression.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nuclear Medicine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nuclear Medicine Market Segments Analysis

Global Nuclear Medicine Market is segmented by Diagnostic Imaging, Therapeutic Applications, Equipment & Technology, End-Users, Radiopharmaceuticals and region. Based on Diagnostic Imaging, the market is segmented into SPECT Imaging and PET Imaging. Based on Therapeutic Applications, the market is segmented into Radiopharmaceutical Therapy and Brachytherapy. Based on Equipment & Technology, the market is segmented into Imaging Devices and Software Solutions. Based on End-Users, the market is segmented into Hospitals and Diagnostic Centers. Based on Radiopharmaceuticals, the market is segmented into Diagnostic Radiopharmaceuticals and Therapeutic Radiopharmaceuticals. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nuclear Medicine Market

One of the key market drivers for the global nuclear medicine market is the increasing prevalence of chronic diseases, such as cancer and cardiovascular disorders, that require advanced diagnostic and therapeutic techniques. Nuclear medicine plays a crucial role in the early detection and treatment of these conditions, utilizing radiopharmaceuticals for both imaging and targeted therapy. Additionally, the growing aging population intensifies the demand for effective medical interventions, further fueling innovations in nuclear medicine technologies. The rising awareness among healthcare professionals and patients regarding the benefits of nuclear medicine also contributes to the market's expansion and adoption in clinical practices worldwide.

Restraints in the Global Nuclear Medicine Market

One significant restraint in the global nuclear medicine market is the stringent regulatory framework governing the production and distribution of radiopharmaceuticals. Compliance with rigorous safety standards and licensing requirements can pose substantial challenges for manufacturers, leading to delays in market entry and increased operational costs. Additionally, concerns regarding the safe handling and disposal of radioactive materials can deter potential investors and limit the expansion of facilities. The growing emphasis on patient safety and environmental impacts further complicates the landscape, creating barriers for innovation and reducing the overall growth potential of the nuclear medicine sector.

Market Trends of the Global Nuclear Medicine Market

The global nuclear medicine market is experiencing a notable trend driven by the rising adoption of theranostics, which integrates diagnostic imaging with targeted radiopharmaceutical therapy. This innovative approach allows for personalized treatment plans that enhance tumor detection and provide simultaneous therapeutic interventions, leading to improved patient outcomes. As a result, there is a growing demand for advanced radiotracers and an expansion of clinical applications, particularly within oncology. The shift towards precision medicine is reshaping the landscape of nuclear medicine, fostering market growth and encouraging the development of new technologies and methodologies aimed at optimizing treatment efficacy and patient care.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Nuclear Medicine Market Size by Diagnostic Imaging & CAGR (2026-2033)

• Market Overview
• SPECT Imaging
  • Cardiac SPECT
  • Oncology SPECT
• PET Imaging
  • FDG-PET
  • Oncologic PET

Global Nuclear Medicine Market Size by Therapeutic Applications & CAGR (2026-2033)

• Market Overview
• Radiopharmaceutical Therapy
  • I-131 Treatment
  • Radium-223 Therapy
• Brachytherapy
  • Permanent Implants
  • Temporary Implants

Global Nuclear Medicine Market Size by Equipment & Technology & CAGR (2026-2033)

• Market Overview
• Imaging Devices
  • Gamma Cameras
  • PET Scanners
• Software Solutions
  • Image Analysis Software
  • Workflow Management Systems

Global Nuclear Medicine Market Size by End-Users & CAGR (2026-2033)

• Market Overview
• Hospitals
  • Academic Hospitals
  • Community Hospitals
• Diagnostic Centers
  • Outpatient Facilities
  • Specialized Clinics

Global Nuclear Medicine Market Size by Radiopharmaceuticals & CAGR (2026-2033)

• Market Overview
• Diagnostic Radiopharmaceuticals
  • Technetium-99m
  • Iodine-123
• Therapeutic Radiopharmaceuticals
  • Yttrium-90
  • Samarium-153

Global Nuclear Medicine Market Size & CAGR (2026-2033)

• North America (Diagnostic Imaging, Therapeutic Applications, Equipment & Technology, End-Users, Radiopharmaceuticals)
  • US
  • Canada
• Europe (Diagnostic Imaging, Therapeutic Applications, Equipment & Technology, End-Users, Radiopharmaceuticals)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Diagnostic Imaging, Therapeutic Applications, Equipment & Technology, End-Users, Radiopharmaceuticals)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Diagnostic Imaging, Therapeutic Applications, Equipment & Technology, End-Users, Radiopharmaceuticals)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Diagnostic Imaging, Therapeutic Applications, Equipment & Technology, End-Users, Radiopharmaceuticals)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bracco Imaging
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Navidea Biopharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Walgreens Boots Alliance
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Accelerator Applications
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lantheus Medical Imaging
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Northstar Medical Radioisotopes
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBA RadioPharma Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M Health Care
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eczacibasi-Monrol
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TAE Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Actinium Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations